Sceletium Tortuosum Benefits: What Science Says About Kanna's Source Plant
If you have been feeling the weight of daily stress more than usual, you are probably not alone. Anxiety, mental fatigue, and emotional burnout have become defining challenges of modern life, and conventional solutions often come with trade-offs nobody wants.
Grogginess, dependency, or the aftermath of one too many drinks are not exactly the outcomes people are looking for. The search for something cleaner, more intentional, and rooted in nature has never been more urgent.
That is exactly where the ancient plant sceletium tortuosum steps into the conversation. Long revered by indigenous South African communities for its mood-lifting and anxiety-reducing qualities, this botanical is now capturing the attention of wellness researchers and functional beverage innovators alike.
At Kamello, we built our entire philosophy around plants like this one. Here we will cover what science and centuries of use reveal about kanna's remarkable source plant.
The Desert Plant That Quietly Changed Everything
Thousands of Years of Calm, Finally Explained
Sceletium tortuosum is a succulent native to the arid regions of South Africa, where the San and Khoikhoi peoples used it for thousands of years as a mood enhancer, hunger suppressant, and social lubricant. They would ferment the plant material and chew or smoke it during long hunts, communal gatherings, and periods of emotional hardship.
Fermentation was not incidental to this process. Research published in the Journal of Ethnopharmacology confirms that fermentation triggers meaningful chemical changes in sceletium tortuosum, converting alkaloid precursors into more bioactive forms and breaking down plant cell walls to increase the availability of active compounds.
What indigenous communities discovered through practice, modern chemistry has since validated. European settlers first documented kanna's use in the late 1600s, and Western researchers began isolating its constituents in the centuries that followed.
Today, sceletium tortuosum appears in supplements, tinctures, and increasingly in functional beverages like Kamello that aim to bring this ethnobotanical knowledge into everyday life.
Why This Plant Does What Nothing Else Quite Does
Most plants associated with relaxation work through sedation. Valerian root is primarily sleep-oriented. Chamomile calms, but mildly. Sceletium tortuosum operates through a more precise mechanism, offering emotional lift alongside anxiety reduction without significant sedation at standard doses.
That dual action is what separates it from the rest of the adaptogen category. Users historically describe feeling more emotionally open, socially at ease, and mentally clear rather than foggy or drowsy.
That profile is increasingly relevant in a culture moving away from alcohol while still seeking a way to decompress and connect. Brands exploring this space, including Kamello, are leaning into this distinction deliberately. The goal is not to mimic intoxication but to offer something more refined: calm without the crash.
Your Brain on Sceletium Tortuosum: The Mechanisms Behind the Mood
The Alkaloids Doing the Heavy Lifting
The primary alkaloids in sceletium tortuosum include mesembrine, mesembrenone, mesembrenol, and tortuosamine. Of these, mesembrine has received the most research attention, identified as a serotonin reuptake inhibitor that helps keep serotonin available in the brain for longer periods.
Mesembrenone adds another layer. It has demonstrated activity as a phosphodiesterase 4 (PDE4) inhibitor, an enzyme that breaks down cyclic AMP, a signaling molecule involved in memory consolidation, emotional regulation, and inflammatory response.
As research in the journal Expert Opinion on Therapeutic Targets has shown, PDE4 inhibition is a well-established pathway for cognitive enhancement and neuroprotection. In plain terms: blocking PDE4 allows brain cells to communicate more efficiently, which may explain the mental clarity users of kanna frequently report alongside its calming effects.
These findings provide a mechanistic framework for what communities experienced for millennia and give researchers a clear direction for future investigation.
What Controlled Trials Are Revealing
A double-blind, randomized, placebo-controlled trial published in Evidence-Based Complementary and Alternative Medicine examined a standardized kanna extract called Zembrin in healthy adults over three weeks. Using a 25mg daily dose, the study found statistically significant improvements in cognitive flexibility, executive function, and self-reported anxiety levels compared to placebo.
Critically, the same research documented a reduction in amygdala reactivity to negative stimuli, a measurable dampening of the brain's threat-response circuitry. This is not a subtle effect. It represents a quantifiable shift in how the brain processes stress, grounded in neuroimaging data rather than self-report alone.
These results do not yet constitute the broad consensus seen with more established compounds. But the trajectory is consistent, and the ethnobotanical record adds substantial weight to the early findings.
When Ancient Botanicals Team Up: Sceletium Tortuosum and Kava
Two Plants, One Remarkable Outcome
Kava (piper methysticum) and sceletium tortuosum address stress and tension from complementary angles. Kava's kavalactones work primarily through GABA receptors and voltage-gated ion channels, producing physical relaxation and reducing social anxiety through a distinctly somatic pathway.
Kanna operates more through serotonergic and cognitive channels, lifting spirits and easing mental tension. When combined, the two may produce synergistic complementarity: each enhancing the therapeutic profile of the other without amplifying unwanted side effects.
It is worth noting that earlier concerns about kava and liver toxicity have been reviewed extensively by the World Health Organization. Findings suggest that hepatotoxicity cases were largely linked to non-noble kava varieties and poor-quality extracts rather than noble kava prepared properly. Kamello sources noble kava specifically for this reason.
This pairing is the principle at the heart of Kamello's formulation, bringing both plants together in a single ready-to-drink can.
Why the Way You Consume It Changes Everything
Delivery format meaningfully affects how much of a plant's active compounds the body can absorb. While fermentation historically improved alkaloid bioavailability in traditional preparation, modern liquid extraction takes a different approach: bypassing fermentation entirely by isolating and concentrating the target compounds directly.
Pharmacokinetic research on oral drug delivery demonstrates that liquid formulations generally produce faster maximum plasma concentration (Cmax) and shorter time-to-peak (Tmax) compared to solid dosage forms such as capsules or powders.
For compounds like those found in kanna, this translates to more consistent onset timing and a more reliable experience overall. That reliability matters enormously for consumer trust in a category still building its credibility.
What No One Tells You About Safety and Regulation
The Honest Truth About Side Effects and Who Should Be Cautious
Sceletium tortuosum has a favorable safety profile at commonly used doses. The most frequently reported side effects are mild and transient: nausea, headache, or slight dizziness, particularly at higher amounts. No serious toxicity has been documented in peer-reviewed literature for oral consumption at standard extract quantities.
One important consideration is its serotonergic activity. Anyone taking prescription antidepressants, particularly SSRIs or MAOIs, should speak with a healthcare provider before using kanna.
Combining serotonin-active substances can, in rare cases, contribute to serotonin syndrome, a condition characterized by agitation, rapid heart rate, and muscle rigidity. As documented in the New England Journal of Medicine, severity varies depending on the degree of serotonergic excess.
At standard doses the risk is considered low, but the interaction warrants clear communication on labeling. That commitment to transparency is central to how Kamello approaches its products.
How Ethnobotanicals Like Kanna Are Regulated
In the United States, sceletium tortuosum is legal and sold as a dietary supplement ingredient under FDA jurisdiction. It is not a scheduled substance. South Africa has designated it as a protected indigenous resource, and bulk export is subject to biodiversity regulations designed to prevent overharvesting.
There is also a broader ethical dimension worth acknowledging. Commercializing plants rooted in San and Khoikhoi culture raises legitimate questions about bioprospecting and intellectual property.
Research published in the Journal of Ethnopharmacology has examined these tensions directly, noting that benefit-sharing agreements and community acknowledgment are important considerations for brands working with heritage botanicals. Honoring both the science and the communities whose knowledge made that science possible is not optional; it is foundational.
From Jungle Tradition to the Beverage Aisle: Where Sceletium Tortuosum Is Headed
The Functional Beverage Category Nobody Saw Coming
The functional beverage industry is one of the fastest-growing sectors in consumer health, with the non-alcoholic segment projected to approach $2 billion by 2026. Within that space, kanna-containing products represent an almost entirely uncharted subcategory.
A small number of companies have introduced kanna-on-tap or kanna shots, but a ready-to-drink canned format combining both kava and kanna is effectively a category unto itself.
Kamello sits at this intersection, designed for consumers who want a sophisticated, ritual-worthy alternative to alcohol that delivers genuine functional benefit. The brand's positioning, "Ancient Roots. Modern Chill," reflects a commitment to honoring ethnobotanical heritage while meeting people where they live: at the end of a long workday, at social gatherings, or in a quiet moment between obligations.
The American Botanical Council maintains one of the most comprehensive databases of peer-reviewed plant research available, and is a valuable resource for anyone looking to go deeper on the ingredients shaping this emerging space.
When Rigorous Research Meets Ancestral Knowledge
The Zembrin trials stand apart from most supplement research for their methodological specificity: 25mg daily doses, double-blind placebo controls, and neuroimaging endpoints that go well beyond self-report questionnaires.
The amygdala reactivity findings in particular represent some of the most compelling neurological evidence for a plant-derived compound in recent memory. They place sceletium tortuosum in a different league from herbs supported only by anecdote.
This research pathway gives wellness-oriented consumers something rare: a plant with both deep cultural roots and an emerging scientific foundation to match. Details on the primary trials cited throughout this article can be reviewed via the National Library of Medicine's PubMed database.
Ready to Experience Kanna for Yourself? Kamello Is Almost Here.
Sceletium tortuosum has earned its place in the conversation. Its mechanisms are grounded in pharmacology, its history spans millennia, and its safety profile supports integration into everyday routines.
Paired with noble kava, whose record has been cleared by rigorous WHO review, the combination represents one of the most thoughtfully supported pairings in the functional beverage space.
What has been missing is a format worthy of these ingredients: something clean, convenient, and designed for people who take their health seriously without taking themselves too seriously.
Kamello was built to fill exactly that gap. Its ready-to-drink format brings both plants together in a single can, making the ritual accessible without sacrificing the integrity of either ingredient.
Check out Kamello’s flavor options today to experience what these plants can offer in a modern format.
Frequently Asked Questions
Does sceletium tortuosum interact with caffeine?
Current evidence does not show a well-established or clinically significant interaction between sceletium tortuosum and caffeine, but this conclusion reflects a lack of targeted research rather than definitive proof of safety.
Human clinical trials on standardized kanna extracts have primarily evaluated mood, cognition, and stress outcomes, not stimulant interactions. For example, a randomized, placebo-controlled trial found a standardized extract to be well tolerated in healthy adults without serious adverse effects, but it did not specifically assess co-use with caffeine.
From a mechanistic standpoint, caffeine and kanna act through different neurochemical pathways. Caffeine primarily functions as an adenosine receptor antagonist, increasing alertness and reducing perceived fatigue, while kanna’s alkaloids influence serotonin reuptake and intracellular signaling pathways.
These pharmacological properties are summarized in a review of sceletium tortuosum pharmacology. Because both compounds affect central nervous system activity, combining them may produce additive or modulating effects depending on the individual.
In practice, responses can vary widely. Some individuals report that kanna softens caffeine-related jitteriness, while others may experience overstimulation when combining substances that influence mood and arousal.
Broader research on caffeine’s physiological and neurological effects highlights the importance of individual sensitivity and dosing, as discussed in this comprehensive review of caffeine’s effects. Given the absence of direct interaction studies, a cautious and individualized approach is warranted.
Is sceletium tortuosum legal everywhere?
Sceletium tortuosum is not classified as a controlled substance at the federal level in the United States and is typically marketed as a dietary supplement ingredient. Under U.S. law, dietary supplements fall under the jurisdiction of the Food and Drug Administration but are regulated as a category of food rather than drugs, meaning they do not require pre-approval for safety or efficacy before being sold.
However, legal status can vary across jurisdictions. While federal classification provides a baseline, individual states or countries may impose additional restrictions on botanical substances, particularly those with psychoactive properties.
The National Institutes of Health emphasizes that supplement regulations differ internationally and may change over time, as explained in this NIH consumer guidance on dietary supplements. This variability makes it important to verify local laws rather than relying on generalized assumptions.
For individuals traveling or purchasing products across borders, checking official regulatory sources is the most reliable approach. Importation rules, labeling requirements, and enforcement practices can differ significantly from domestic regulations.
Because sceletium tortuosum occupies a gray area between traditional botanical use and modern functional products, its legal treatment may continue to evolve as regulatory frameworks adapt.
Does sceletium tortuosum affect appetite or weight?
Ethnobotanical records indicate that sceletium tortuosum was historically used by indigenous South African communities to suppress hunger during extended periods without food.
This traditional use is documented in scientific literature that examines both cultural applications and pharmacological properties, including this review of sceletium tortuosum and its uses. However, historical use alone does not establish clinical effectiveness.
Modern research has not confirmed sceletium tortuosum as a reliable tool for weight management or appetite control. While its serotonergic activity provides a plausible biological mechanism, serotonin is known to influence satiety and appetite signaling pathways in the brain. Even so, the presence of a theoretical mechanism does not equate to clinically meaningful outcomes.
At present, there are no large-scale human trials demonstrating that kanna produces consistent or sustained effects on appetite or body weight. Any appetite-related changes reported by users are likely to be variable and secondary to its broader effects on mood and perception. For this reason, sceletium tortuosum should not be considered an evidence-based strategy for weight loss, and its traditional use in this context should be interpreted cautiously.
How is sceletium tortuosum typically standardized in commercial products?
Commercial sceletium tortuosum products are commonly standardized to specific concentrations of total alkaloids, particularly mesembrine, which is one of the primary compounds associated with its serotonergic activity.
Standardization is intended to ensure consistency across batches, allowing consumers to receive a predictable amount of active constituents rather than relying on raw plant variability.
One of the most studied standardized extracts is Zembrin, which has been used in multiple human clinical trials. For example, a placebo-controlled study using a standardized extract found improvements in cognitive flexibility and executive function at a daily dose of 25 mg.
Additional research has examined its effects on stress and emotional processing, with findings suggesting measurable reductions in stress reactivity, as described in this human study on stress and anxiety responses.
It is important to recognize that not all standardized products are equivalent to those used in clinical research. Differences in extraction methods, alkaloid profiles, and manufacturing quality can influence both safety and effectiveness.
While standardization improves reliability, it does not guarantee that a product will replicate outcomes observed in controlled trials. Evaluating both the standardization details and the supporting evidence for a specific extract is essential.
Can sceletium tortuosum be used during pregnancy or breastfeeding?
There is currently no high-quality clinical research evaluating the safety of sceletium tortuosum during pregnancy or breastfeeding. Most clinical trials involving dietary supplements exclude these populations due to ethical and safety concerns, which means that a lack of evidence should not be interpreted as evidence of safety.
Health authorities generally recommend avoiding non-essential supplements during pregnancy and lactation unless they have been specifically studied and shown to be safe. The National Institutes of Health notes that dietary supplements are not routinely evaluated in pregnant or breastfeeding individuals.
Similarly, the FDA emphasizes that supplements can have biological effects and should be used cautiously in vulnerable populations, as explained in this FDA consumer overview of dietary supplements.
Given kanna’s activity on neurotransmitter systems, including serotonin pathways, a precautionary approach is appropriate. Individuals who are pregnant, breastfeeding, or planning to become pregnant should consult a qualified healthcare provider before using serotonergic or psychoactive botanicals. This recommendation reflects a broader safety principle rather than a specific known risk.
Can sceletium tortuosum be used to treat anxiety or depression?
Sceletium tortuosum has shown promising early findings in research related to mood and stress, but it is not approved as a treatment for anxiety, depression, or other medical conditions.
In the United States, dietary supplements are not permitted to make disease-treatment claims unless they undergo formal drug approval processes. This distinction is explained in the FDA’s guidance on structure and function claims.
Clinical studies using standardized extracts have demonstrated measurable effects on stress and emotional processing. For example, a placebo-controlled trial found that participants taking a standardized extract experienced reduced stress reactivity and improved mood-related outcomes. Reviews of sceletium tortuosum also highlight its serotonergic and PDE4-related activity as plausible mechanisms for these effects.
Despite these findings, the current evidence base is still limited compared to established treatments such as psychotherapy or FDA-approved medications. There are no large, long-term trials demonstrating equivalent efficacy or safety.
As a result, sceletium tortuosum is best understood as a complementary wellness ingredient rather than a replacement for evidence-based mental health care. Individuals experiencing persistent or severe symptoms should seek guidance from qualified healthcare professionals.